Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Ranibizumab is a monoclonal antibody fragment obtained from the same parental murine antibody as bevacizumab. It is an anti-angiogenic drug that has been approved for the treatment of AMD patients.
This report presents a comprehensive overview, market shares and growth opportunities of Ranibizumab market by product type, application, key companies and key regions. Biomedicine has achieved rapid growth in the global pharmaceutical market due to its high pharmacological activity, strong specificity, and good therapeutic effect. In the biopharmaceutical market, the monoclonal antibody is the most subdivided category. With the development of biotechnology, the research on monoclonal antibodies will be further deepened, and the patients' demand for monoclonal antibodies will also be further increased. Ranibizumab is mainly used for the treatment of age-related macular degeneration (AMD), a retinal disease that increases the incidence with age and causes a significant decrease in vision. Diabetic retinopathy and diabetic macular edema can also be treated with ranibizumab. Therefore, the deepening of global aging and the increasing incidence of chronic diseases such as diabetes will promote the expansion of demand for ranibizumab.
Indian pharmaceutical company Intas Pharmaceuticals has launched RAZUMAB™, a biosimilar of Lucentis® (Ranibizumab). The product is entirely manufactured in India, and the price of RAZUMAB™ is much cheaper than Lucentis®, which will allow the drug to be used in a wider patient population.
This report offers an overview of the market trends, drivers, and barriers with respect to the China Ranibizumab market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Ranibizumab market. Detailed analysis of key players, along with key growth strategies adopted by Ranibizumab industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Genentech
Novartis
By Type:
Single-use prefilled syringe
Single-use glass vial
By End-User:
AMD
Diabetic Retinopathy (DR)
Diabetic Macular Edema (DME)
mCNV
RVO
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Ranibizumab Market
-
1.3 Market Segment by Type
-
1.3.1 China Ranibizumab Market Size and Growth Rate of Single-use prefilled syringe from 2016 to 2027
-
1.3.2 China Ranibizumab Market Size and Growth Rate of Single-use glass vial from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Ranibizumab Market Size and Growth Rate of AMD from 2016 to 2027
-
1.4.2 China Ranibizumab Market Size and Growth Rate of Diabetic Retinopathy (DR) from 2016 to 2027
-
1.4.3 China Ranibizumab Market Size and Growth Rate of Diabetic Macular Edema (DME) from 2016 to 2027
-
1.4.4 China Ranibizumab Market Size and Growth Rate of mCNV from 2016 to 2027
-
1.4.5 China Ranibizumab Market Size and Growth Rate of RVO from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Ranibizumab Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Ranibizumab Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Ranibizumab Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Ranibizumab Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Ranibizumab Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Ranibizumab Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Ranibizumab Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Ranibizumab Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Ranibizumab by Major Types
-
3.4.1 Market Size and Growth Rate of Single-use prefilled syringe
-
3.4.2 Market Size and Growth Rate of Single-use glass vial
4 Segmentation of Ranibizumab Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Ranibizumab by Major End-Users
-
4.4.1 Market Size and Growth Rate of Ranibizumab in AMD
-
4.4.2 Market Size and Growth Rate of Ranibizumab in Diabetic Retinopathy (DR)
-
4.4.3 Market Size and Growth Rate of Ranibizumab in Diabetic Macular Edema (DME)
-
4.4.4 Market Size and Growth Rate of Ranibizumab in mCNV
-
4.4.5 Market Size and Growth Rate of Ranibizumab in RVO
5 Market Analysis by Regions
-
5.1 China Ranibizumab Production Analysis by Regions
-
5.2 China Ranibizumab Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Ranibizumab Landscape Analysis
-
6.1 North China Ranibizumab Landscape Analysis by Major Types
-
6.2 North China Ranibizumab Landscape Analysis by Major End-Users
7 Central China Ranibizumab Landscape Analysis
-
7.1 Central China Ranibizumab Landscape Analysis by Major Types
-
7.2 Central China Ranibizumab Landscape Analysis by Major End-Users
8 South China Ranibizumab Landscape Analysis
-
8.1 South China Ranibizumab Landscape Analysis by Major Types
-
8.2 South China Ranibizumab Landscape Analysis by Major End-Users
9 East China Ranibizumab Landscape Analysis
-
9.1 East China Ranibizumab Landscape Analysis by Major Types
-
9.2 East China Ranibizumab Landscape Analysis by Major End-Users
10 Northeast China Ranibizumab Landscape Analysis
-
10.1 Northeast China Ranibizumab Landscape Analysis by Major Types
-
10.2 Northeast China Ranibizumab Landscape Analysis by Major End-Users
11 Southwest China Ranibizumab Landscape Analysis
-
11.1 Southwest China Ranibizumab Landscape Analysis by Major Types
-
11.2 Southwest China Ranibizumab Landscape Analysis by Major End-Users
12 Northwest China Ranibizumab Landscape Analysis
-
12.1 Northwest China Ranibizumab Landscape Analysis by Major Types
-
12.2 Northwest China Ranibizumab Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 Genentech
-
13.1.1 Genentech Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 Novartis
-
13.2.1 Novartis Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Ranibizumab Market Size and Growth Rate of Single-use prefilled syringe from 2016 to 2027
-
Figure China Ranibizumab Market Size and Growth Rate of Single-use glass vial from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Ranibizumab Market Size and Growth Rate of AMD from 2016 to 2027
-
Figure China Ranibizumab Market Size and Growth Rate of Diabetic Retinopathy (DR) from 2016 to 2027
-
Figure China Ranibizumab Market Size and Growth Rate of Diabetic Macular Edema (DME) from 2016 to 2027
-
Figure China Ranibizumab Market Size and Growth Rate of mCNV from 2016 to 2027
-
Figure China Ranibizumab Market Size and Growth Rate of RVO from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Ranibizumab Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Ranibizumab Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Ranibizumab Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Ranibizumab Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Ranibizumab Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Ranibizumab Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Ranibizumab Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Ranibizumab Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Ranibizumab
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Ranibizumab by Different Types from 2016 to 2027
-
Table Consumption Share of Ranibizumab by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Single-use prefilled syringe
-
Figure Market Size and Growth Rate of Single-use glass vial
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Ranibizumab by Different End-Users from 2016 to 2027
-
Table Consumption Share of Ranibizumab by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of AMD
-
Figure Market Size and Growth Rate of Diabetic Retinopathy (DR)
-
Figure Market Size and Growth Rate of Diabetic Macular Edema (DME)
-
Figure Market Size and Growth Rate of mCNV
-
Figure Market Size and Growth Rate of RVO
-
Table China Ranibizumab Production by Regions
-
Table China Ranibizumab Production Share by Regions
-
Figure China Ranibizumab Production Share by Regions in 2016
-
Figure China Ranibizumab Production Share by Regions in 2021
-
Figure China Ranibizumab Production Share by Regions in 2027
-
Table China Ranibizumab Consumption by Regions
-
Table China Ranibizumab Consumption Share by Regions
-
Figure China Ranibizumab Consumption Share by Regions in 2016
-
Figure China Ranibizumab Consumption Share by Regions in 2021
-
Figure China Ranibizumab Consumption Share by Regions in 2027
-
Table North China Ranibizumab Consumption by Types from 2016 to 2027
-
Table North China Ranibizumab Consumption Share by Types from 2016 to 2027
-
Figure North China Ranibizumab Consumption Share by Types in 2016
-
Figure North China Ranibizumab Consumption Share by Types in 2021
-
Figure North China Ranibizumab Consumption Share by Types in 2027
-
Table North China Ranibizumab Consumption by End-Users from 2016 to 2027
-
Table North China Ranibizumab Consumption Share by End-Users from 2016 to 2027
-
Figure North China Ranibizumab Consumption Share by End-Users in 2016
-
Figure North China Ranibizumab Consumption Share by End-Users in 2021
-
Figure North China Ranibizumab Consumption Share by End-Users in 2027
-
Table Central China Ranibizumab Consumption by Types from 2016 to 2027
-
Table Central China Ranibizumab Consumption Share by Types from 2016 to 2027
-
Figure Central China Ranibizumab Consumption Share by Types in 2016
-
Figure Central China Ranibizumab Consumption Share by Types in 2021
-
Figure Central China Ranibizumab Consumption Share by Types in 2027
-
Table Central China Ranibizumab Consumption by End-Users from 2016 to 2027
-
Table Central China Ranibizumab Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Ranibizumab Consumption Share by End-Users in 2016
-
Figure Central China Ranibizumab Consumption Share by End-Users in 2021
-
Figure Central China Ranibizumab Consumption Share by End-Users in 2027
-
Table South China Ranibizumab Consumption by Types from 2016 to 2027
-
Table South China Ranibizumab Consumption Share by Types from 2016 to 2027
-
Figure South China Ranibizumab Consumption Share by Types in 2016
-
Figure South China Ranibizumab Consumption Share by Types in 2021
-
Figure South China Ranibizumab Consumption Share by Types in 2027
-
Table South China Ranibizumab Consumption by End-Users from 2016 to 2027
-
Table South China Ranibizumab Consumption Share by End-Users from 2016 to 2027
-
Figure South China Ranibizumab Consumption Share by End-Users in 2016
-
Figure South China Ranibizumab Consumption Share by End-Users in 2021
-
Figure South China Ranibizumab Consumption Share by End-Users in 2027
-
Table East China Ranibizumab Consumption by Types from 2016 to 2027
-
Table East China Ranibizumab Consumption Share by Types from 2016 to 2027
-
Figure East China Ranibizumab Consumption Share by Types in 2016
-
Figure East China Ranibizumab Consumption Share by Types in 2021
-
Figure East China Ranibizumab Consumption Share by Types in 2027
-
Table East China Ranibizumab Consumption by End-Users from 2016 to 2027
-
Table East China Ranibizumab Consumption Share by End-Users from 2016 to 2027
-
Figure East China Ranibizumab Consumption Share by End-Users in 2016
-
Figure East China Ranibizumab Consumption Share by End-Users in 2021
-
Figure East China Ranibizumab Consumption Share by End-Users in 2027
-
Table Northeast China Ranibizumab Consumption by Types from 2016 to 2027
-
Table Northeast China Ranibizumab Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Ranibizumab Consumption Share by Types in 2016
-
Figure Northeast China Ranibizumab Consumption Share by Types in 2021
-
Figure Northeast China Ranibizumab Consumption Share by Types in 2027
-
Table Northeast China Ranibizumab Consumption by End-Users from 2016 to 2027
-
Table Northeast China Ranibizumab Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Ranibizumab Consumption Share by End-Users in 2016
-
Figure Northeast China Ranibizumab Consumption Share by End-Users in 2021
-
Figure Northeast China Ranibizumab Consumption Share by End-Users in 2027
-
Table Southwest China Ranibizumab Consumption by Types from 2016 to 2027
-
Table Southwest China Ranibizumab Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Ranibizumab Consumption Share by Types in 2016
-
Figure Southwest China Ranibizumab Consumption Share by Types in 2021
-
Figure Southwest China Ranibizumab Consumption Share by Types in 2027
-
Table Southwest China Ranibizumab Consumption by End-Users from 2016 to 2027
-
Table Southwest China Ranibizumab Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Ranibizumab Consumption Share by End-Users in 2016
-
Figure Southwest China Ranibizumab Consumption Share by End-Users in 2021
-
Figure Southwest China Ranibizumab Consumption Share by End-Users in 2027
-
Table Northwest China Ranibizumab Consumption by Types from 2016 to 2027
-
Table Northwest China Ranibizumab Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Ranibizumab Consumption Share by Types in 2016
-
Figure Northwest China Ranibizumab Consumption Share by Types in 2021
-
Figure Northwest China Ranibizumab Consumption Share by Types in 2027
-
Table Northwest China Ranibizumab Consumption by End-Users from 2016 to 2027
-
Table Northwest China Ranibizumab Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Ranibizumab Consumption Share by End-Users in 2016
-
Figure Northwest China Ranibizumab Consumption Share by End-Users in 2021
-
Figure Northwest China Ranibizumab Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Genentech
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genentech
-
Figure Sales and Growth Rate Analysis of Genentech
-
Figure Revenue and Market Share Analysis of Genentech
-
Table Product and Service Introduction of Genentech
-
Table Company Profile and Development Status of Novartis
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis
-
Figure Sales and Growth Rate Analysis of Novartis
-
Figure Revenue and Market Share Analysis of Novartis
-
Table Product and Service Introduction of Novartis
-
